ClinicalTrials.Veeva

Menu
A

Ascada Research | Fullerton, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ritonavir
PF-07321332
Ensovibep
Vancomycin
sodium
PBI-0451
Pomotrelvir
Obeldesivir
EDP-938
Dupilumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 16 total trials

A Pilot Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment

Some people who have been infected with the virus that causes COVID-19 can experience long-term effects from their infection, known as post COVID-19...

Not yet enrolling
Post COVID-19 Cognitive Impairment
Device: Vielight Neuro RX Gamma sham device
Device: Vielight Neuro RX Gamma active device

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult sub...

Enrolling
RSV Infection
Drug: Placebo
Drug: EDP-938

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

The purpose of this research is to evaluate the primary objectives of safety and efficacy (rate of clinical cure) of 2 dosages of CRS3123 (200 mg and...

Active, not recruiting
Clostridioides Difficile Infection
Drug: Active Comparator
Drug: CRS3123

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI-0451(Pomotrelvir)...

Active, not recruiting
COVID-19
Drug: Placebo
Drug: PBI-0451 (Pomotrelvir)

The purpose of this study is to measure the proportion of participants who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-Co...

Enrolling
SARS-CoV-2 Infection
Drug: Placebo
Drug: S-217622

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

Trial sponsors

Pfizer logo
Novartis logo
C
Enanta Pharmaceuticals logo
Gilead Sciences logo
Masimo logo
Merck Sharp & Dohme (MSD) logo
Moderna logo
P
Sanofi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems